PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1980 June; 73(6): 431–436.
PMCID: PMC1437605

Neuropharmacological agents modifying endotoxin-induced changes in mice1

Abstract

A variety of neuropharmacological agents were tested to elucidate how chlorpromazine influenced an endotoxin-induced reaction. The results obtained, particularly with beta-adrenergic blocking agents, reserpine and fusaric acid, suggested that the primary locus of chlorpromazine's action was mediated by peripheral beta-adrenergic receptor blockade. Such a locus is compatible with the low doses of propranolol which suppress the reaction, and with successful treatment of shock with dopamine.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (943K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Andén NE, Butcher SG, Corrodi H, Fuxe K, Ungerstedt U. Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol. 1970;11(3):303–314. [PubMed]
  • Andén NE, Dahlström A, Fuxe K, Larsson K. Functional role of the nigro-neostriatal dopamine neurons. Acta Pharmacol Toxicol (Copenh) 1966;24(2):263–274. [PubMed]
  • Apperley E, Humphrey PP, Levy GP. Receptors for 5-hydroxytryptamine and noradrenaline in rabbit isolated ear artery and aorta. Br J Pharmacol. 1976 Oct;58(2):211–221. [PMC free article] [PubMed]
  • Banerjee SP, Kung LS, Riggi SJ, Chanda SK. Development of beta-adrenergic receptor subsensitivity by antidepressants. Nature. 1977 Aug 4;268(5619):455–456. [PubMed]
  • Benedict CR, Grahame-Smith DG. Plasma noradrenaline and adrenaline concentrations and dopamine-beta-hydroxylase activity in patients with shock due to septicaemia, trauma and haemorrhage. Q J Med. 1978 Jan;47(185):1–20. [PubMed]
  • Bennett JP, Jr, Snyder SH. Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors. Mol Pharmacol. 1976 May;12(3):373–389. [PubMed]
  • Bopp B, Biel JH. Antidepressant drugs. Life Sci. 1974 Feb 1;14(3):415–423. [PubMed]
  • Carlsson A, Corrodi H, Fuxe K, Hökfelt T. Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine. Eur J Pharmacol. 1969 Mar;5(4):357–366. [PubMed]
  • Carlsson A, Corrodi H, Fuxe K, Hökfelt T. Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,alpha-dimethyl-meta-tyramine. Eur J Pharmacol. 1969 Mar;5(4):367–373. [PubMed]
  • Carlsson A, Jonason J, Lindqvist M, Fuxe K. Demonstration of extraneuronal 5-hydroxytryptamine accumulation in brain following membrane-pump blockade by chlorimipramine. Brain Res. 1969 Feb;12(2):456–460. [PubMed]
  • CARLSSON A, LINDQVIST M, MAGNUSSON T. 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature. 1957 Nov 30;180(4596):1200–1200. [PubMed]
  • Charalampous KD, Askew WE. Effect of non-opiate antagonists on stereospecific opiate receptor binding of tritiated naloxone. Res Commun Chem Pathol Pharmacol. 1974 Aug;8(4):615–622. [PubMed]
  • COSTA E. Effects of hallucinogenic and tranquilizing drugs on serotonin evoked uterine contractions. Proc Soc Exp Biol Med. 1956 Jan;91(1):39–41. [PubMed]
  • Creese I, Burt DR, Synder SH. The dopamine receptor: differential binding of d-LSD and related agents to agonist and antagonist states. Life Sci. 1975 Dec 1;17(11):1715–1719. [PubMed]
  • Des Prez RM, Oates JA. Lack of relationship of febrile response to endotoxin and brain stem 5-hydroxytryptamine. Proc Soc Exp Biol Med. 1968 Mar;127(3):793–794. [PubMed]
  • DINGELL JV, SULSER F, GILLETTE JR. SPECIES DIFFERENCES IN THE METABOLISM OF IMIPRAMINE AND DESMETHYLIMIPRAMINE (DMI). J Pharmacol Exp Ther. 1964 Jan;143:14–22. [PubMed]
  • Giordano J, Zinner M, Guba A, Lynch N. Effects of H1 and H2 histamine antagonists on the pulmonary pressor response to alveolar hypoxia. J Surg Res. 1977 Apr;22(4):392–397. [PubMed]
  • Goldberg LI. Dopamine--clinical uses of an endogenous catecholamine. N Engl J Med. 1974 Oct 3;291(14):707–710. [PubMed]
  • Green JP, Maayani S. Tricyclic antidepressant drugs block histamine H2 receptor in brain. Nature. 1977 Sep 8;269(5624):163–165. [PubMed]
  • Hidaka H. Fusaric (5-butylpicolinic) acid, an inhibitor of dopamine beta-hydroxylase, affects serotonin and noradrenaline. Nature. 1971 May 7;231(5297):54–55. [PubMed]
  • Hirata M. Inhibitory effects of antihistamines and antiserotonins on the bone marrow reactions produced by Escherichia coli endotoxin in mice. J Infect Dis. 1975 Dec;132(6):611–616. [PubMed]
  • Holaday JW, Faden AI. Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock. Nature. 1978 Oct 5;275(5679):450–451. [PubMed]
  • Iversen LL, Rogawski MA, Miller RJ. Comparison of the effects of neuroleptic drugs on pre- and postsynaptic dopaminergic mechanisms in the rat striatum. Mol Pharmacol. 1976 Mar;12(2):251–262. [PubMed]
  • Jacobs BL. Evidence for the functional interaction of two central neurotransmitters. Psychopharmacologia. 1974;39(1):81–86. [PubMed]
  • Koe BK, Weissman A. p-Chlorophenylalanine: a specific depletor of brain serotonin. J Pharmacol Exp Ther. 1966 Dec;154(3):499–516. [PubMed]
  • KRONEBERG G, KURBJUWEIT HG. [Control of experimental fever by reserpine and sympatholytics in guinea pigs]. Arzneimittelforschung. 1959 Sep;9:556–558. [PubMed]
  • Lamkin N, Jr, Lieberman P, Shereff R, Rosenberg EW, Robinson H. Effect of beta adrenergic stimulation and blockade on cutaneous reactivity to histamine. J Allergy Clin Immunol. 1976 May;57(5):449–453. [PubMed]
  • Lassen JB, Petersen E, Kjellberg B, Olsson SO. Comparative studies of a new 5HT-uptake inhibitor and some tricyclic thymoleptics. Eur J Pharmacol. 1975 May;32(1):108–115. [PubMed]
  • Lemaire I, Tseng R, Lemaire S. Systemic administration of beta-endorphin: potent hypotensive effect involving a serotonergic pathway. Proc Natl Acad Sci U S A. 1978 Dec;75(12):6240–6242. [PubMed]
  • Lemberger L, Rowe H, Carmichael R, Oldham S, Horng JS, Bymaster FP, Wong DT. Pharmacologic effects in man of a specific serotonin-reuptake inhibitor. Science. 1978 Jan 27;199(4327):436–437. [PubMed]
  • Leszkovszky G, Tardos L. Some effects of propranolol on the central nervous system. J Pharm Pharmacol. 1965 Aug;17(8):518–519. [PubMed]
  • McGrath MA, Shepherd JT. Inhibition of adrenergic neurotransmission in canine vascular smooth muscle by histamine: mediation by H2-receptors. Circ Res. 1976 Oct;39(4):566–573. [PubMed]
  • Maickel RP. Diverse central effects of chlorpromazine. Int J Neuropharmacol. 1968 Jan;7(1):23–27. [PubMed]
  • Moroni F, Fantozzi R, Masini E, Mannaioni PF. The influence of catecholamines and serotonin on histamine uptake and metabolism by guinea pig atrium. Eur J Pharmacol. 1977 Jan 7;41(1):59–63. [PubMed]
  • O'Keeffe R, Sharman DF, Vogt M. Effect of drugs used in psychoses on cerebral dopamine metabolism. Br J Pharmacol. 1970 Feb;38(2):287–304. [PMC free article] [PubMed]
  • ORLANS FB, BRODIE BB, SHEPPARD H, ZIMMERMAN JH. A suggested effect on levels of catecholamine in brain produced by small doses of reserpine. Nature. 1960 Sep 17;187:1034–1035. [PubMed]
  • PARANT M, CHEDID L. PROTECTIVE EFFECT OF CHLORPROMAZINE AGAINST ENDOTOXIN-INDUCED ABORTION. Proc Soc Exp Biol Med. 1964 Aug-Sep;116:906–909. [PubMed]
  • Pinder RM, Brogden RN, Swayer R, Speight TM, Spencer R, Avery GS. Pimozide: a review of its pharmacological properties and therapeutic uses in psychiatry. Drugs. 1976;12(1):1–40. [PubMed]
  • Pinder RM, Brogden RN, Swayer R, Speight TM, Spencer R, Avery GS. Pimozide: a review of its pharmacological properties and therapeutic uses in psychiatry. Drugs. 1976;12(1):1–40. [PubMed]
  • PLETSCHER A, SHORE PA, BRODIE BB. Serotonin release as a possible mechanism of reserpine action. Science. 1955 Aug 26;122(3165):374–375. [PubMed]
  • Reinhold RB, Fine J. A technique for quantitative measurement of endotoxin in human plasma. Proc Soc Exp Biol Med. 1971 May;137(1):334–340. [PubMed]
  • Sayers AC, Bürki HR, Ruch W, Asper H. Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine. Psychopharmacologia. 1975;41(2):97–104. [PubMed]
  • Snyder SH, Banerjee SP, Yamamura HI, Greenberg D. Drugs, neurotransmitters, and schizophrenia. Science. 1974 Jun 21;184(4143):1243–1253. [PubMed]
  • Steinburg MI, Holland DR. Separate receptors mediating the positive inotropic and chronotropic effect of histamine in guinea-pig atria. Eur J Pharmacol. 1975 Nov;34(1):95–104. [PubMed]
  • Steinsland OS, Hieble JP. Dopaminergic inhibition of adrenergic neurotransmission as a model for studies on dopamine receptor mechanisms. Science. 1978 Jan 27;199(4327):443–445. [PubMed]
  • Tampier L, Alpers HS, Davis VE. Influence of catecholamine-derived alkaloids and beta-adrenergic blocking agents on stereospecific binding of 3H-naloxone. Res Commun Chem Pathol Pharmacol. 1977 Aug;17(4):731–734. [PubMed]
  • Greengrass PM, Tonge SR. Effects of oestrogen and progesterone on brain monoamines: interactions with psychotropic drugs. J Pharm Pharmacol. 1972 Dec;24(Suppl):149P–149P. [PubMed]
  • Van Arman CG, Carlson RP, Brown WR, Itkin A. Indomethacin inhibits the local Shwartzman reaction. Proc Soc Exp Biol Med. 1970 May;134(1):163–168. [PubMed]
  • Vetulani J, Sulser F. Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain. Nature. 1975 Oct 9;257(5526):495–496. [PubMed]
  • Vetulani J, Stawarz RJ, Dingell JV, Sulser F. A possible common mechanism of action of antidepressant treatments: reduction in the sensitivity of the noradrenergic cyclic AMP gererating system in the rat limbic forebrain. Naunyn Schmiedebergs Arch Pharmacol. 1976 May;293(2):109–114. [PubMed]
  • Walinder J, Skott A, Carlsson A, Nagy A, Bjorn-Erik R. Potentiation of the antidepressant action of clomipramine by tryptophan. Arch Gen Psychiatry. 1976 Nov;33(11):1384–1389. [PubMed]
  • YASUDA M. Effect of reserpine on febrile responses induced by pyrogenic substances. Jpn J Pharmacol. 1962 Mar;11:114–125. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press